BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24813748)

  • 1. Advanced diagnostic imaging in privately insured patients: recent trends in utilization and payments.
    Horný M; Burgess JF; Horwitt J; Cohen AB
    J Am Coll Radiol; 2014 Jul; 11(7):692-7. PubMed ID: 24813748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced Imaging Utilization Trends in Privately Insured Patients From 2007 to 2013.
    Horný M; Burgess JF; Cohen AB
    J Am Coll Radiol; 2015 Dec; 12(12 Pt B):1380-1387.e4. PubMed ID: 26614883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization trends for advanced imaging procedures: evidence from individuals with private insurance coverage in California.
    Mitchell JM
    Med Care; 2008 May; 46(5):460-6. PubMed ID: 18438193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization Trends in Diagnostic Imaging for a Commercially Insured Population: A Study of Massachusetts Residents 2009 to 2013.
    Flaherty S; Mortele KJ; Young GJ
    J Am Coll Radiol; 2018 Jun; 15(6):834-841. PubMed ID: 29661520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in the utilization of medical imaging from 2003 to 2011: clinical encounters offer a complementary patient-centered focus.
    Dodoo MS; Duszak R; Hughes DR
    J Am Coll Radiol; 2013 Jul; 10(7):507-12. PubMed ID: 23827002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between availability of health service prices and payments for these services.
    Whaley C; Schneider Chafen J; Pinkard S; Kellerman G; Bravata D; Kocher R; Sood N
    JAMA; 2014 Oct 22-29; 312(16):1670-6. PubMed ID: 25335149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth in spending on substance use disorder treatment services for the privately insured population.
    Thomas CP; Hodgkin D; Levit K; Mark TL
    Drug Alcohol Depend; 2016 Mar; 160():143-50. PubMed ID: 26781063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of a no-denial policy on imaging utilization.
    Robinson JD; Hippe DS; Hiatt MD
    J Am Coll Radiol; 2013 Jul; 10(7):501-6. PubMed ID: 23632131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using Medical Claims for Policy Effectiveness Surveillance: Reimbursement and Utilization of Abdomen/Pelvis Computed Tomography Scans.
    Horný M; Morgan JR; Merker VL
    Health Serv Res; 2015 Dec; 50(6):1910-26. PubMed ID: 25752473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The sharp reductions in medicare payments for noninvasive diagnostic imaging in recent years: will they satisfy the federal policymakers?
    Levin DC; Rao VM; Parker L; Frangos AJ
    J Am Coll Radiol; 2012 Sep; 9(9):643-7. PubMed ID: 22954546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Who gets paid for diagnostic imaging, and how much?
    Levin DC; Rao VM; Parker L; Maitino AJ; Sunshine JH
    J Am Coll Radiol; 2004 Dec; 1(12):931-5. PubMed ID: 17411735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal testing utilization and payments in a large cohort of commercially insured US adults.
    Ladabaum U; Levin Z; Mannalithara A; Brill JV; Bundorf MK
    Am J Gastroenterol; 2014 Oct; 109(10):1513-25. PubMed ID: 24980877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation In Health Spending Growth For The Privately Insured From 2007 To 2014.
    Cooper Z; Craig S; Gray C; Gaynor M; Van Reenen J
    Health Aff (Millwood); 2019 Feb; 38(2):230-236. PubMed ID: 30715989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in Diagnostic Imaging Utilization among Medicare and Commercially Insured Adults from 2003 through 2016.
    Hong AS; Levin D; Parker L; Rao VM; Ross-Degnan D; Wharam JF
    Radiology; 2020 Feb; 294(2):342-350. PubMed ID: 31891320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare expenditures for privately insured people with cystic fibrosis.
    Ouyang L; Grosse SD; Amendah DD; Schechter MS
    Pediatr Pulmonol; 2009 Oct; 44(10):989-96. PubMed ID: 19768806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Payment reform--the need to harmonize approaches in Medicare and the private sector.
    Lee PV; Berenson RA; Tooker J
    N Engl J Med; 2010 Jan; 362(1):3-5. PubMed ID: 20007550
    [No Abstract]   [Full Text] [Related]  

  • 17. Private expenditure and the role of private health insurance in Greece: status quo and future trends.
    Siskou O; Kaitelidou D; Economou C; Kostagiolas P; Liaropoulos L
    Eur J Health Econ; 2009 Oct; 10(4):467-74. PubMed ID: 19593628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The sharp slowdown in growth of medical imaging: an early analysis suggests combination of policies was the cause.
    Lee DW; Levy F
    Health Aff (Millwood); 2012 Aug; 31(8):1876-84. PubMed ID: 22842655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Out-of-Pocket Payment for Ambulatory Blood Pressure Monitoring Among Commercially Insured in the United States.
    Desai R; Dietrich EA; Park H; Smith SM
    Am J Hypertens; 2020 Nov; 33(11):999-1002. PubMed ID: 32930343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Payment levels, resource use, and insurance risk of medicaid versus private insured in three states.
    Adams EK; Bronstein JM; Becker ER; Hood CR
    J Health Care Finance; 2001; 28(1):72-91. PubMed ID: 11669295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.